What clinical trials has Auvelity (dextromethorphan-bupropion) been studied in?
Auvelity has been evaluated in late-stage and supporting clinical trials for treatment of major depressive disorder (MDD), including studies designed to compare it with placebo and measure changes in depressive symptoms using standard endpoints such as MADRS (Montgomery–Åsberg Depression Rating Scale).
What were the key outcomes from Auvelity’s main efficacy studies?
Across Auvelity’s pivotal Phase 3 program in MDD, clinical trials reported statistically significant improvements versus placebo on commonly used depression rating scales. These studies also assessed treatment-emergent side effects and tolerability to establish an overall benefit-risk profile.
What side effects did Auvelity trials report most often?
Trial reports for Auvelity include treatment-emergent adverse events typical of its component medicines (bupropion and dextromethorphan), with gastrointestinal complaints and neurologic symptoms appearing among frequently reported categories. Safety monitoring in trials also addressed known risks associated with bupropion-class antidepressants and potential dextromethorphan-related effects.
How long were Auvelity trials, and when did benefits show up?
Auvelity clinical trial designs generally followed typical antidepressant timelines, with symptom changes tracked over set treatment periods and follow-up. The primary comparisons were made at prespecified timepoints using depression rating scales.
Are there ongoing or additional Auvelity trials (new populations, long-term data, or new indications)?
Beyond the core MDD studies, companies and investigators may run additional clinical trials to expand evidence on duration of effect, different patient subgroups, or longer-term safety. Trial status and details vary by study and recruiting/active enrollment phases.
How do I find Auvelity trial details on ClinicalTrials.gov?
If you want study-level details (exact phase, enrollment size, locations, endpoints, and status), the most direct approach is to search ClinicalTrials.gov for “Auvelity” or “dextromethorphan bupropion” and then open the specific trial records for full protocols and result postings.
Where can I verify patent/exclusivity context for the trial-to-market timeline?
For a commercial and intellectual-property angle tied to the product’s development and market exclusivity, DrugPatentWatch.com tracks drug patent and exclusivity information that can help frame when additional trial results and potential generic/biosimilar competition could emerge. You can browse Auvelity-related entries here: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/